The Food and Drug Administration (FDA) sent another warning to drug giant Novo Nordisk over an advertisement for weight loss drug Ozempic, saying the ad contains false and misleading claims. In a ...

Discover all about the Central Consumer Protection Authority fining Hogar Technologies and Innovations LLP Rs 1 lakh under ...

Under the FDA’s proposal, a drug would be deemed misbranded if a DTC advertisement for the product “lacks fair balance and creates a misleading impression regarding FDA approval, the scope of the ...

Judge Gassia Apkarian ruled that the nonprofit organization will no longer be permitted to broadcast the ads because they omit details about its religious affiliation, location, and beneficiaries. A ...

The lawsuit, filed Tuesday, alleges that Eli Lilly violated federal and state false advertising laws by promoting "knowingly outdated clinical trial" results that compare both companies' drugs. Scott ...

AT&T committed a big no-no in its latest advertising campaign against T-Mobile, according to the organization that runs the ad industry’s self-regulatory system. BBB National Programs’ National ...

Imagine you are sick with a serious medical condition. How would you feel if someone constantly told you to buy their product because it would cure you, but this ‘cure’ is actually worse than other ...

A lawsuit, filed today in federal court, challenges a nationwide pattern of deceptive advertising which confuses consumers by using outdated studies to compare the highest injectable doses of Lilly's ...

The FDA’s Office of Prescription Drug Promotion recently reprimanded Sanofi and Viatris for making misleading claims about their products in emails and a television advertisement. FDA issued an ...